On May 27, 2026 Sapreme Development reported as company continues to evolve, it is excited to announce that effective June 1st, 2026, Sapreme Development B.V. will become Sapreme Therapeutics B.V.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Over the past years, our focus has progressed from platform technology toward the development of a growing portfolio of therapeutic programs.

Our new name reflects that evolution and our future as a therapeutics-focused biotech company.

This is a name change only, and we look forward to continuing this journey together with our partners, collaborators, and broader network.

(Press release, Sapreme Technologies, MAY 27, 2026, View Source [SID1234666088])